The Biomedical Excellence for Safer Transfusion (BEST) Collaborative is an international research organization that works collaboratively to explore ways to improve transfusion-related services through standardization of analytic techniques, development of new procedures, systematic review of evidence, and execution of clinical and laboratory studies. We currently operate in teams covering 4 areas: Conventional Blood Components, Clinical Transfusion Studies , Cellular Therapy, and, our newest team, Donor Studies.

We have 42 scientific members, 13 manufacturing sponsors and 17 blood service sponsors from 22 countries representing a diversity of interests and high levels of accomplishment. The supporting members of BEST span a broad range of the companies and blood suppliers engaged with blood collection, distribution and transfusion worldwide. We also have been pleased to have some participation from regulatory agencies such as FDA and the Paul Ehrlich Institute. BEST has published 114 peer reviewed papers and has 35 studies currently open. As part of our mission, BEST believes it brings to the community thoughtful consideration to identify important questions in Transfusion Medicine, design and execute studies to address these questions, and provide critical thought and synthesis of the available evidence.